Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
orthotopic mouse glioma model compared with AZ31
Oral administration of CX-4945 at 25 mg/kg or 75 mg/kg twice daily displays potent antitumor activity in the BT-474 model
InChi: InChI=1S/C41H43Cl2F2N7O3/c42-32-9-6-10-33(43)31(32)25-52-24-28(23-51-17-4-5-18-51)30-13-12-29(21-38(30)52)48-41(55)50-37(20-27-11-14-34(44)35(45)19-27)40(54)49-36(15-16-46)39(53)47-22-26-7-2-1-3-8-26/h1-3
AMPA receptors and NMDA receptors) and release of BDNF
ClH/c1-4-25(31)19-11-21-22-17(12-28(21)23(29)18(19)13-32-24(25)30)15(9-10-26-14(2)3)16-7-5-6-8-20(16)27-22
YS-201 Size:Contact [email protected] for quotation orthotopic mouse glioma model comparedYS 201 is a dihydropyridine type calcium channel antagonist. YS 201 has the potential for angina pectoris and hypertension treatment. Product information CAS Number: 108852 42 2 Molecular Weight: 457. 52 Formula: C24H31N3O6 Chemical Name: 3 ethyl 5 [2 (piperidin 1 yl)ethyl] 2,6 dimethyl 4 (3 nitrophenyl) 1,4 dihydropyridine 3,5 dicarboxylate Smiles: CCOC(=O)C1C(C(C(=O)OCCN2CCCCC2)=C(C)NC=1C)C1C=C(C=CC=1)[N+]([O ])=O InChiKey: LBSRZVRITCRLIU UHFFFAOYSA
US$ 1127.49
US$ 1369.90
US$ 1414.72
US$ 995.02
US$ 1336.09
US$ 913.29
US$ 1657.42
US$ 1212.07